LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to ’sell’

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following London-listed shares received analyst recommendations Friday morning and on Thursday:

----------

FTSE 100

----------

Deutsche Bank cuts AstraZeneca to ’sell’ (hold) - price target 10,500 (11,000) pence

----------

Jefferies raises Haleon price target to 450 (410) pence - ’buy’

----------

HSBC cuts ConvaTec price target to 320 (350) pence - ’buy’

----------

HSBC raises Entain price target to 935 (925) pence - ’buy’

----------

FTSE 250

----------

Exane BNP cuts Great Portland to ’underperform’ (neutral) - price target 310 (340) pence

----------

RBC raises Travis Perkins price target to 1,150 (950) pence - ’outperform’

----------

HSBC cuts Computacenter price target to 3,400 (3,525) pence - ’buy’

----------

JPMorgan raises Spectris price target to 3,000 (2,950) pence - ’neutral’

----------

Deutsche Bank raises Trainline price target to 530 (470) pence - ’buy’

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Deutsche Bank raises CRH price target to 7,813 (7,660) EUR - ’buy’

----------

JPMorgan cuts Fevertree Drinks price target to 900 (1,090) pence - ’neutral’

----------

RBC cuts Fevertree Drinks price target to 1,000 (1,200) pence - ’sector perform’

----------

Peel Hunt cuts Fevertree Drinks price target to 650 (700) pence - ’reduce’

----------

Berenberg raises Andrada Mining price target to 11 (10) pence - ’buy’

----------

Berenberg cuts Pan African Resources price target to 33 (38) pence - ’buy’

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.